Mitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications.

Distinct architectures of midbody remnants in somatic mitosis and oocyte meiosis are linked to their functions and clinical applications.

• Why it matters: Understanding midbody remnant biology is crucial because it may reveal new biomarkers and therapeutic targets for cancer and reproductive health, yet their roles remain poorly characterized.
• What they did: The review compares midbody remnants in symmetric somatic cell division and asymmetric oocyte meiosis, highlighting differences in structure, cargo, and fate, based on existing studies.
• The result: Findings suggest division mode influences midbody architecture and translational activity, potentially impacting cell regulation, cancer diagnostics, and reproductive development.